| Host: |
Rabbit |
| Applications: |
WB/ELISA/IHC |
| Reactivity: |
Human/Mouse/Rat |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-Myosin-binding protein C, slow-type (218-267) is suitable for use in Western Blot, ELISA and Immunohistochemistry research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
WB 1:500-2000IHC-p 1:50-300ELISA 2000-20000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
MYBPC1 |
| Gene ID: |
4604 |
| Uniprot ID: |
MYPC1_HUMAN |
| Immunogen Region: |
218-267 |
| Specificity: |
MYBPC1 Polyclonal Antibody detects endogenous levels of MYBPC1 protein. |
| Immunogen: |
The antiserum was produced against synthesized peptide derived from human MYBPC1. AA range:218-267 |
| Function | Thick filament-associated protein located in the crossbridge region of vertebrate striated muscle a bands. Slow skeletal protein that binds to both myosin and actin. In vitro, binds to native thin filaments and modifies the activity of actin-activated myosin ATPase. May modulate muscle contraction or may play a more structural role. |
| Protein Name | Myosin-Binding Protein C - Slow-TypeSlow Mybp-CC-Protein - Skeletal Muscle Slow Isoform |
| Database Links | Reactome: R-HSA-390522 |
| Alternative Antibody Names | Anti-Myosin-Binding Protein C - Slow-Type antibodyAnti-Slow Mybp-C antibodyAnti-C-Protein - Skeletal Muscle Slow Isoform antibodyAnti-MYBPC1 antibodyAnti-MYBPCS antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
